Adjuvant chemotherapy for resected adenocarcinoma of the esophagus, gastro-esophageal junction, and cardia: Phase II trial (E8296) of the Eastern Cooperative Oncology Group

Journal of Clinical Oncology

Volumn 22, Issue 22, 2004, Pages 4495-4499

  Armanios, Mary ^a   Xu, Ronghui ^a   Forastiere, Arlene A ^a   Haller, Daniel G ^a   Kugler, John W ^a   Benson III, Al B ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIA; CARDIA CARCINOMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; HUMAN; LEUKOPENIA; LOWER ESOPHAGUS SPHINCTER; LYMPH NODE; MAJOR CLINICAL STUDY; METABOLIC DISORDER; NAUSEA AND VOMITING; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; TREATMENT OUTCOME; ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGED; ESOPHAGUS TUMOR; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTICENTER STUDY; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PACLITAXEL; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 16544380956     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.06.533     Document Type: Article

References (24)

1. Schrump DS, Forastiere AA, Minsky BD: Cancer of the Esophagus, in DeVita V (ed): Cancer: Principles and Practice of Oncology. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 1051-1091
2. Urba SG, Orringer MB, Turrisi A, et al: Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 19: 305-313, 2001
3. Mariette C, Balon JM, Piessen G, et al: Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease. Cancer 97:1616-1623, 2003
4. MacDonald WC, MacDonald JB: Adenocarcinoma of the esophagus and/or gastric cardia. Cancer 60:1094-1098, 1987
5. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
6. Ando N, Iizuka T, Ide H, et al: Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 21:4592-4596, 2003
7. Kelsen DP, Ginsberg R, Pajak TF, et al: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 339:1979-1984, 1998
8. Salazar JD, Doty JR, Lin JW, et al: Does cell type influence post-esophagectomy survival in patients with esophageal cancer? Dis Esophagus 11:168-171, 1998
9. Leichman L, Steiger Z, Seydel HG, et al: Preoperative chemotherapy and radiation therapy for patients with cancer of the esophagus: A potentially curative approach. J Clin Oncol 2:75-79, 1984
10. Kelsen D, Ajani J, Ilson D, et al: A phase II trial of paclitaxel (Taxol) in advanced esophageal cancer: Preliminary report. Semin Oncol 21:44-48, 1994
11. Ajani JA, Ilson DH, Daugherty K, et al: Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86:1086-1091, 1994
12. Ilson DH, Forastiere A, Arquette M, et al: A phase II trial of paclitaxel and cisplatin in patients with advanced carcinoma of the esophagus. Cancer J 6:316-323, 2000
13. Kelsen D, Ginsberg R, Bains M, et al: A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: A preliminary report. Semin Oncol 24: S19-77-S19-81, 1997
14. American Joint Committee on Cancer, Esophagus and Gastric (5th ed). Philadelphia, J.B. Lippincott, 1997
15. Luketich JD, Schauer PR, Meltzer CC, et al: Role of positron emission tomography in staging esophageal cancer. Ann Thorac Surg 64:765-769, 1997
16. Kole AC, Plukker JT, Nieweg OE, et al: Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 78:521-527, 1998
17. Rasanen JV, Sihvo EI, Knuuti MJ, et al: Prospective analysis of accuracy of positron emission tomography, computed tomography, and endoscopic ultrasonography in staging of adenocarcinoma of the esophagus and the esophagogastric junction. Ann Surg Oncol 10: 954-960, 2003
18. Gibson MK, Forastiere AA: Combined-modality therapy for esophageal cancer: Are we making progress? Cancer J 9:238-240, 2003
19. Walsh TN, Noonan N, Hollywood D, et al: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 335:462-467, 1996
20. Bosset JF, Gignoux M, Triboulet JP, et al: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 337:161-167, 1997
21. Medical Research Council Oesophageal Cancer Working Group: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: A randomised controlled trial. Lancet 359:1727-1733, 2002
22. Kleinberg L, Knisely JP, Heitmiller R, et al: Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancer. Int J Radiat Oncol Biol Phys 56:328-334, 2003
23. Heath EI, Burtness BA, Heitmiller RF, et al: Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol 18:868-876, 2000
24. Ajani JA, Faust J, Yao J, et al: Irinotecan/ cisplatin followed by 5-FU/paclitaxel/radiotherapy and surgery in esophageal cancer. Oncology (Huntingt) 17:20-22, 2003